Wellgistics Health has made a significant leadership change by appointing Mark DiSiena as its new Chief Financial Officer (CFO). This strategic move is aimed at enhancing the company's growth initiatives. DiSiena will play a crucial role in a wide array of financial and strategic functions within the organization.
DiSiena's responsibilities at Wellgistics (WGRX, Financial) will include overseeing corporate finance, ensuring compliance with SEC reporting, managing treasury activities, and handling financial planning and analysis. In addition, he will be in charge of taxation, accounting, investor relations, procurement, internal audit, and risk management. Moreover, he will focus on optimizing ERP systems and steering the corporate strategy.
With over three decades of experience as a CFO in both public and private sectors, DiSiena brings a wealth of knowledge and expertise to his new role. His background includes a blend of active Certified Public Accountant (CPA) practice and previous legal experience in securities and taxation. Notably, he founded Cresset Advisors, a consulting firm that specializes in delivering customized interim CFO and advisory services, providing operational leadership and accounting oversight to various clients.
This appointment is expected to bolster Wellgistics’ strategic objectives and solidify its financial management practices, paving the way for future growth and development.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
